Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 125.69% | 8.76% | -547.81% | 113.50% | -139.06% |
| Total Depreciation and Amortization | 7.44% | -0.17% | 3.48% | -10.64% | 14.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -205.18% | 38.45% | 147.55% | -242.50% | 459.59% |
| Change in Net Operating Assets | 241.72% | -106.09% | 786.17% | -115.06% | 7,976.74% |
| Cash from Operations | 99.19% | -111.17% | 323.80% | -158.70% | 332.34% |
| Capital Expenditure | 29.21% | 25.14% | -376.15% | 21.01% | 12.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -169.71% | 121.93% | -5,649.65% | 86.30% | -95,642.86% |
| Cash from Investing | -174.60% | 120.98% | -5,089.13% | 84.98% | -4,450.67% |
| Total Debt Issued | 6,158.18% | 350.00% | -100.27% | 1,069.98% | -75.95% |
| Total Debt Repaid | 8.40% | 0.54% | 0.53% | -2.51% | 0.93% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,075.00% | 90.24% | -63.27% | 89.50% | -255.83% |
| Cash from Financing | 169.35% | -105.37% | 559.97% | -71.39% | 2,363.27% |
| Foreign Exchange rate Adjustments | 8.22% | -223.77% | 777.53% | -115.65% | 229.14% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -200.00% | -- | -- | 0.00% |
| Net Change in Cash | -257.64% | -61.47% | 289.79% | -119.81% | 507.27% |